FDA Drug Application (050233) for CANDEX by BAYER PHARMS

Back to FDA Applications sponsored by BAYER PHARMS

Application Number050233
Product Number001
FormLOTION;TOPICAL
Dosage100,000 UNITS/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCANDEX
Active IngredientNYSTATIN

Active IngredientCount
List of drugs with Active Ingredient NYSTATIN18


Back to FDA Applications sponsored by BAYER PHARMS